Sleep Apnea After Extubation

• Sponsor: Seoul National University Hospital (Other)
• Overall Status: Completed
• CT.gov ID: NCT03770715
• Collaborator: (none)
• Enrollment: 13
• Location: 1
• Actual Duration (Months): 15.5
• Patients Per Site Per Month: 0.8

Study Details

Study Description

Brief Summary

Sleep apnea is common after extubation, approximately 71%, and is independently associated with hypertension and metabolic disease contributing to increased morbidity and mortality. Respiratory polygraphy is a simpler alternative to in-laboratory polysomnography for the management of more symptomatic patients with obstructive sleep apnea.

The aim of this study is to evaluate the prevalence of sleep apnea after extubation by respiratory polygraphy.

Condition or Disease	Intervention/Treatment	Phase
Sleep Apnea	Device: Respiratory polygraphy

Study Design

• Study Type: Observational [Patient Registry]
• Actual Enrollment: 13 participants
• Observational Model: Cohort
• Time Perspective: Prospective
• Official Title: Sleep Apnea After Extubation
• Actual Study Start Date: Aug 17, 2018
• Actual Primary Completion Date: May 24, 2019
• Actual Study Completion Date: Dec 2, 2019

Outcome Measures

Primary Outcome Measures

1. Prevalence of sleep apnea after exutbation [during first to second night following extubation]

Eligibility Criteria

Criteria

• Ages Eligible for Study: 18 Years to 99 Years
• Sexes Eligible for Study: All
• Accepts Healthy Volunteers: No

Inclusion Criteria:

• patients after extubation

Exclusion Criteria:

• pregnant

• non-consciousness

• received continuous positive airway pressure (CPAP)

Contacts and Locations

Locations

	Site	City	State	Country	Postal Code
1	Seoul National University Hospital	Seoul		Korea, Republic of	110744

Sponsors and Collaborators

• Seoul National University Hospital

Investigators

• Principal Investigator: Jaeyoung Cho, MD, Seoul National University Hospital

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.

• Responsible Party: Jaeyoung Cho, Assistant Professor, Seoul National University Hospital
• ClinicalTrials.gov Identifier: NCT03770715
• Other Study ID Numbers: 1802051921
• First Posted: Dec 10, 2018
• Last Update Posted: Dec 3, 2019
• Last Verified: Dec 1, 2019

• Studies a U.S. FDA-regulated Drug Product: No
• Studies a U.S. FDA-regulated Device Product: No
• Keywords provided by Jaeyoung Cho, Assistant Professor, Seoul National University Hospital: Sleep Apnea; Respiratory polygraphy; Extubation
• Additional relevant MeSH terms: Apnea; Sleep Apnea Syndromes

Study Results

No Results Posted as of Dec 3, 2019